CIK: 1743662 - Address: C/O Allovir, Inc., 1100 Winter Street, Waltham, MA 02451
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/18/22 16:05
11/16/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-1217.500-16-5334D
11/15/22 16:53
11/11/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-3008.200-37-9350D
11/10/22 17:29
11/8/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.m-1078.000-13-3386D
10/26/22 16:15
10/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.a-109.360-10400D
10/24/22 18:26
10/19/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-109.360-10400D
9/6/22 16:17
9/2/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-47.89000401D
8/17/22 17:58
8/16/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-1298.300-16-4401D
7/21/22 19:11
7/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-65.210-10402D
7/6/22 07:30
6/3/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.d-23.630-10403D
5/18/22 08:57
5/17/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-674.400-15-4390D
4/22/22 08:28
4/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-66.680-10405D
3/3/22 16:15
3/2/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-59.010-10382D
2/18/22 16:30
2/16/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-1288.320-15-4383D
1/24/22 16:15
1/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-418.750-5-1398D
12/3/21 16:14
12/2/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-917.060-10403D
11/18/21 16:30
11/16/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-32121.130-15-4403D
10/1/21 17:58
9/29/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.m-41725.140-17-4419D
9/20/21 18:33
2/17/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.m-1,41026.570-53-11435D
3/3/21 20:36
3/1/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-23038.780-6-1488D
2/23/21 19:44
2/19/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.m-37741.460-9-2494D
2/19/21 08:41
2/18/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-8540.670-20503D
2/18/21 21:20
2/16/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS.m-22341.220-5-1505D
2/4/21 16:35
2/2/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagVan Beek Jeroen BMAOChief CoS-2,01541.190-49-9511D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact